The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid in the following packs: Trelegy Ellipta ... (100 or 200 mcg per blister), and the other strip ...
The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults, adding to its existing use in chronic obstructive pulmonary disease (COPD), stealing a march on rivals ...
The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to be used in a broader population of patients with chronic obstructive pulmonary disease ...